Form 4: Myriad Genetics CEO Paul Diaz Sells Shares to Cover Tax Obligations

Paul Diaz, CEO of Myriad Genetics, disposed of shares to cover tax obligations related to vesting restricted stock units.

Summary

• On March 14 and 15, 2025, Paul J. Diaz, the President and CEO of Myriad Genetics Inc., disposed of shares of common stock to cover tax withholding obligations.
• A total of 37,564 shares were disposed of on March 14, 2025, and 30,118 shares were disposed of on March 15, 2025, both at a price of $10.07 per share.
• Following these transactions, Diaz directly owns 1,009,524 shares of Myriad Genetics Inc.
• The shares were withheld by the company to satisfy tax obligations related to the vesting of restricted stock units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing relates to a standard transaction for tax purposes and doesn't indicate any fundamental change in the company's prospects.

Industry Context

This is a routine transaction where company executives sell shares to cover tax obligations arising from the vesting of stock options or restricted stock units. It is a common practice and doesn't necessarily indicate a negative outlook on the company.

Comparison to Industry Standards

• Stock sales to cover tax obligations are a common practice among executives in publicly traded companies, including those in the biotechnology and healthcare sectors.
• Comparable companies like Exact Sciences, Illumina, and Quest Diagnostics often see similar filings from their executives related to stock transactions for tax purposes.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates